Boston Scientific Corp

Stock Chart, Company Information, and Scan Results

$103.18(as of Jul 22, 3:59 PM EST)

Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.

Boston Scientific Corp Company Information, Fundamentals, and Technical Indicators

Stock Price$103.18
Ticker SymbolBSX
ExchangeNyse
SectorHealthcare
IndustryMedical Devices
Employees53,000
CountyUSA
Market Cap$153,537.3M
EBIDTA4,536.0M
10-Day Moving Average103.63
P/E Ratio75.80
20-Day Moving Average104.11
Forward P/E Ratio35.59
50-Day Moving Average103.44
Earnings per Share1.37
200-Day Moving Average97.10
Profit Margin14.45%
RSI48.70
Shares Outstanding1,479.5M
ATR1.94
52-Week High107.53
Volume6,456,951
52-Week Low71.88
Most Recent Support Level102.26
Book Value22,446.0M
Most Recent Resistance Level105.40
P/B Ratio6.86
Upper Keltner108.48
P/S Ratio8.78
Lower Keltner99.73
Debt-to-Equity Ratio108.48
Next Earnings Date10/22/2025
Cash Surplus-4,333.0M
Next Ex-Dividend DateUnknown

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal surgery and infection prevention portfolios; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, urinary and bowel dysfunction, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, penile implants, artificial urinary sphincter, laser system, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator systems, proprietary programming software, radiofrequency ablation, indirect decompression systems, and intraosseous nerve ablation and deep brain stimulation systems. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a left atrial appendage closure (LAAC) device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat, and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Boston Scientific Corp In Our Stock Scanner

example chart graphic
Date: Jul 22, 2025Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Increasing Profit MarginScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Low Debt with 20%+ Return on EquityScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Earnings AnnouncementsScan Type: Stock Fundamentals
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Channel Pattern RangeScan Type: Chart Pattern Scans
As of ---
example chart graphic
Date: Jul 22, 2025Scan Name: Channel Pattern RangeScan Type: Chart Pattern Scans
As of ---

Join Our Free Email List

Get emails from us about ways to potentially make money in the stock market.